People with obstructive sleep apnea may have a higher risk of developing Parkinson’s disease, but early use of continuous positive airway pressure (CPAP) therapy could help lower that risk. A ...

The gold standard for moderate to severe obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP) therapy. For a CPAP machine alone, it can cost anywhere from $500 to $1000 or more.

Dear Savvy Senior: I’ve been diagnosed with sleep apnea and have been trying to use a CPAP device for the past six months but can’t tolerate it. Are there any alternative treatment options? — Sleepy ...

Obstructive sleep apnea, a breathing disorder where the airway becomes blocked during sleep, comes with numerous health risks ...

Continuous positive airway pressure (CPAP) is the gold standard treatment for moderate-to-severe obstructive sleep apnea. But it may not be effective in adults aged 80 years and older, a new study ...

Please provide your email address to receive an email when new articles are posted on . More patients without continuous airway positive pressure coverage in their region said that cost affected their ...

Please provide your email address to receive an email when new articles are posted on . Patients with moderate to severe obstructive sleep apnea and no use of continuous positive airway pressure had ...

A retrospective cohort study examined data on 54,224 OSA patients, the vast majority of whom had CPAP during an 8-year period. Soft tissue surgery was associated with a lower incidence of ...

If you have obstructive sleep apnea (OSA)—a condition that causes a partial or complete collapse of your upper airway while sleeping—you’re likely familiar with continuous positive airway pressure ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Sleep apnea can result in daytime fatigue and irritability. Obstructive Sleep Apnea, defined as having frequent episodes of ...

“ProSomnus delivered another record setting quarter further establishing ProSomnus as the leading non-CPAP therapy for Obstructive Sleep Apnea. An estimated 3 to 5 million people have OSA, have been ...